ARCHIVES

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Long-Term Estrogen Use May Increase Ovarian Cancer Risk

April 27, 2001

NCI Intramural Research: More Than 200 Scientists At Frederick To Become NCI Employees This Year

March 26, 1999

Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher

May 27, 1994

Comprehensive Centers Could Lose That Designation By Not Producing

May 30, 1975

Consensus conference On Cervical Cancer

January 26, 1996

Funding Opportunities: Komen Foundation Seeks Reviewers

February 28, 1997